Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris

被引:47
作者
Balamurugan, V [1 ]
Renji, R [1 ]
Saha, SN [1 ]
Reddy, GR [1 ]
Gopalakrishna, S [1 ]
Suryanarayana, VVS [1 ]
机构
[1] Indian Vet Res Inst, Mol Virol Lab, Bangalore 560024, Karnataka, India
关键词
FMDV type O; recombinant P1; Pichia pastoris; immune response;
D O I
10.1016/S0168-1702(02)00357-X
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Foot and mouth disease virus (FMDV) is the aetiological agent of a highly contagious vesicular disease of cloven-hooved animals. The gene coding for the capsid polyprotein (P1) of FMDV from serotype 'O' vaccine strain (O75Madras) was cloned and expressed in yeast Pichia pastoris. The expressed P1 protein was characterised by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western Blot analysis. Immunisation of Guinea pigs with recombinant P1 induced FMDV type O specific immune response. The Immoral response to vaccine was measured by indirect ELISA and a serum neutralisation test (SNT). The Guinea pig sera showed high titres both in ELISA and SNT. Upon challenge with virulent Guinea pig adapted homologous type 'O' virus, the animals showed a protective index of 2.52. This study shows that the yeast expressed FMDV P1 could be a safe vaccine in non-endemic countries and a cost-effective vaccine in endemic countries. This is the first report on the production of FMDV structural proteins in yeast and their application as a vaccine. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 149
页数:9
相关论文
共 50 条
[1]   ASSEMBLY OF FOOT-AND-MOUTH-DISEASE VIRUS EMPTY CAPSIDS SYNTHESIZED BY A VACCINIA VIRUS EXPRESSION SYSTEM [J].
ABRAMS, CC ;
KING, AMQ ;
BELSHAM, GJ .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :3089-3098
[2]   ENZYME-LABELED IMMUNOSORBENT ASSAY TECHNIQUES IN FOOT-AND-MOUTH-DISEASE VIRUS RESEARCH [J].
ABUELZEIN, EME ;
CROWTHER, JR .
JOURNAL OF HYGIENE, 1978, 80 (03) :391-399
[3]   THE 3-DIMENSIONAL STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS AT 2.9-A RESOLUTION [J].
ACHARYA, R ;
FRY, E ;
STUART, D ;
FOX, G ;
ROWLANDS, D ;
BROWN, F .
NATURE, 1989, 337 (6209) :709-716
[4]  
ANDERSON EC, 1971, RES VET SCI, V12, P342
[5]  
BACHRACH HL, 1975, J IMMUNOL, V115, P1636
[6]  
BAHNEMANN H, 1987, MODERN APPROACHES AN, V1, P628
[7]  
BANERJEE K, 2000, THESIS DEEMED U UP I
[8]   International bank for foot-and-mouth disease vaccine: Assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants [J].
Barnett, PV ;
Pullen, L ;
Williams, L ;
Doel, TR .
VACCINE, 1996, 14 (13) :1187-1198
[9]   DEVELOPMENTS IN FOOT-AND-MOUTH-DISEASE VACCINES [J].
BARTELING, SJ ;
VREESWIJK, J .
VACCINE, 1991, 9 (02) :75-88
[10]  
Bayry J, 1999, VACCINE, V17, P2333